In a randomized, double-blind trial, gamma radiation-sterilized, chlorhexidine-coated triple-lumen catheters were compared with uncoated control catheters for their ability to prevent catheter infection in 254 intensive care unit patients. The chlorhexidine coating was not efficacious, and a rabbit model demonstrated that reduction of chlorhexidine activity by gamma radiation sterilization was the likely explanation for the failure.
In a randomized, double-blind trial, gamma radiation-sterilized, chlorhexidine-coated triple-lumen catheters were compared with uncoated control catheters for their ability to prevent catheter infection in 254 intensive care unit patients. The chlorhexidine coating was not efficacious, and a rabbit model demonstrated that reduction of chlorhexidine activity by gamma radiation sterilization was the likely explanation for the failure.
There is growing interest in developing vascular catheters with anti-infective properties (1, 2, 4, 6-8, 10-13). Chlorhexidine has been of particular interest as a catheter coating because it has broad-spectrum antimicrobial activity against organisms that cause vascular catheter infections (12) and there is a lower risk of inflammation with chlorhexidine-coated catheters than with uncoated control catheters in a rabbit model, volunteers, and patients (3, 15) . The present study evaluated the efficacy of a chlorhexidine coating at preventing triplelumen catheter-related infections in intensive care unit patients.
MATERIALS AND METHODS
The catheters used in the clinical trial were polyurethane (Vialon), triplelumen catheters manufactured by Becton-Dickinson Vascular Access (Sandy, Utah). The catheters coated with chlorhexidine were identical in appearance to uncoated catheters. The catheters were sterilized with gamma irradiation.
This was a two-armed, randomized, double-blind, multicenter trial. It was carried out in the intensive care units of four tertiary-care university hospitals: University of Massachusetts, Worcester; M. D. Anderson Cancer Center, Houston, Tex.; St. Luke's Hospital, Houston, Tex.; and North Carolina Baptist Hospital, Winston-Salem. Patients were excluded from the study if they were less than 18 years of age, had dermatitis over the proposed insertion site, had neutropenia (Ͻ1,000 neutrophils per ml) were pregnant, or were allergic to topical disinfectants including chlorhexidine. No patient was enrolled in the study twice.
Catheters were inserted by attending physicians, fellows, residents, or students. The catheters were monitored daily for evidence of local-site abnormalities, and dressings were changed at least every 48 h. While the catheter was in place, all drugs administered were recorded. At the time of catheter removal the indication for removal was noted and cultures were done.
Prior to catheter removal a quantitative peripheral blood culture was performed by percutaneous venipuncture. One milliliter of heparinized (without preservatives) blood was added to 19 ml of molten agar (45ЊC), and the components were mixed. All colonies obtained over 7 days of incubation were counted and identified. Prior to catheter removal 1 ml of blood was aspirated through each catheter lumen (if feasible) and cultured as described above. If blood could not be aspirated, an attempt was made to flush broth (4 ml of tryptic soy broth three times) through the lumen as described by Cleri et al. (5) .
The tip and the subcutaneous segment of each catheter were cultured as follows: either by the roll plate method (9) and then sonication (14) or by the roll plate method plus sonication of an immediately adjacent segment.
Catheter infection was defined as a colony count of Ն15 CFU by the roll plate method or Ն100 CFU by sonication, a colony count of Ն100 CFU by flush culture, or a ratio of catheter lumen blood CFU/peripheral blood CFU of Ն5. A patient was defined as having catheter-related bacteremia when there was a catheter infection and a culture of peripheral blood grew the same organism that grew in the culture of the catheter.
Triple-lumen catheters were coated with chlorhexidine at the same or twice the concentration used in the clinical trial. Catheters were sterilized (i) with gamma radiation, (ii) with ethylene oxide, or (iii) by presterilizing the catheter (ethylene oxide) and then coating it with chlorhexidine. These three types of catheters were compared with uncoated control catheters in a rabbit model of subcutaneous Staphylococcus aureus catheter infection by using an inoculum of 10 4 CFU of S. aureus and a duration of infection of 7 days as reported previously (12) .
To evaluate the comparability of the two groups of patients, proportions were compared by Fisher's exact test or the chi-square test, while continuous variables were compared by Student's t test or the Mann-Whitney test. Risk of infection and bacteremia were assessed by using Kaplan-Meier survival estimates and were then compared by the log rank test and the generalized Wilcoxon test.
The original sample size for the study was calculated to be 400 on the basis of an anticipated catheter-related bacteremia rate of 7%, with an anticipated reduction in that rate to 1%, a power of 0.8, and an alpha value of 0.05. When 218 patients had been enrolled in the study, an interim analysis was performed. On the basis of a lack of any differences between the two experimental groups, the study was terminated.
RESULTS
A total of 263 patients were enrolled in the study at the four study sites; of these, 254 were evaluable. Of the nine unevaluable patients, the catheters were removed from eight patients without culturing and incomplete data entry occurred for one patient. The randomization into two groups was effective because no significant differences between the chlorhexidine and control groups were detected (Table 1) .
Overall there were no significant differences between the two catheter groups with regard to the site of insertion, the level of training of the inserter, the duration of catheterization (uncoated catheter group, 8.8 Ϯ 8.1 days; coated catheter group, 7.9 Ϯ 7.0 days), indication for the use of the catheter, or the indication for its removal ( Table 1) .
The catheter infection rates were not different between the chlorhexidine-coated catheter group and the uncoated control catheter group. Overall the catheter colonization rates were 34.1% for uncoated catheters and 37.6% for coated catheters. Colonization rates varied somewhat for uncoated versus coated catheters between institutions, but they were not significantly different within institutions: institution 1, 5 of 29 (17.2%) versus 3 of 23 (13.0%); institution 2, 7 of 32 (21.9%) versus 11 of 29 (37.9%); institution 3, 18 of 40 (45.0%) versus 17 of 40 (42.5%); and institution 4, 3 of 25 (52.0%) versus 16 of 33 (48.5%). Catheter-related bacteremia rates were 2.4% for those with uncoated catheters and 5.6% for those with coated catheters. A survival curve for catheter-related infection is provided in Fig. 1 . There were no statistical differences between the two groups for either catheter-related infection (P ϭ 0.195; generalized Wilcoxon test) or catheter-related bacteremia (survival curve not shown) (P ϭ 0.55; generalized Wilcoxon test).
The organisms causing catheter infection are listed in Table  2 . Sixty-three percent of the isolates were staphylococci. The only significant difference between the two groups was that greater numbers of diphtheroids were isolated from individuals in the uncoated catheter group (P Ͻ 0.05). Catheter-related bacteremias were caused by Candida albicans (n ϭ 1), S. aureus (n ϭ 1), and coagulase-negative staphylococci (n ϭ 4) in the chlorhexidine-coated catheter group and by Pseudomonas putida (n ϭ 1), S. aureus (n ϭ 2), and coagulase-negative staphylococci (n ϭ 1) in the control group.
Catheters that were coated with chlorhexidine at the same concentration used in the clinical trial and that were presterilized or sterilized with ethylene oxide after coating were both efficacious at preventing S. aureus infection in the rabbit model in comparison with control catheters (P Ͻ 0.05); catheters sterilized with gamma radiation were not efficacious at preventing S. aureus infection (Table 3) . Notably, for catheters that were presterilized there was a lower risk of infection than that for gamma radiation-sterilized catheters by both quantitative culture (P ϭ 0.02) and purulence (P ϭ 0.04). When twice the chlorhexidine concentration used in the clinical trial was used to coat the catheters, all three methods of sterilizing the catheters resulted in chlorhexidine coatings that were efficacious (P Ͻ 0.05).
DISCUSSION
In the present study triple-lumen, polyurethane catheters coated with chlorhexidine were not efficacious at preventing catheter infections in intensive care unit patients in comparison with uncoated control catheters. In previous rabbit model studies, chlorhexidine-coated catheters identical to those used in the present study had a lower risk of infection than uncoated catheters (12) . Notably, in a previous study of phlebitis associated with peripheral catheters with the same chlorhexidine coating, there was no reduction in the risk of catheter colonization (15) . Lack of coating efficacy in the present study was not related to organism resistance, because Streptococcus epidermidis strains from the present study (unpublished data) and a previous study (15) were as susceptible to the chlorhexidine coating as the S. aureus strain used in the rabbit model.
A careful reevaluation of how the chlorhexidine-coated catheters were prepared suggested that the method of catheter sterilization might be the explanation for the lack of efficacy of the chlorhexidine coating. For the rabbit model studies (12) , polyurethane catheters were first sterilized with ethylene oxide and were then aseptically coated with chlorhexidine. For the two clinical trials, the present study and the phlebitis study (15) , the catheters were first coated with chlorhexidine, and then underwent sterilization with gamma radiation. In a rabbit model gamma radiation destroyed the efficacy of the chlorhexidine coating used in the present study, whereas ethylene oxide sterilization preserved the chlorhexidine activity. If the quantity of chlorhexidine in the coating was increased, even gammaradiated catheters remained efficacious. It seems prudent that medical devices coated with chlorhexidine probably not be sterilized with gamma radiation. 
